Affiliation:
1. Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) Université de Sherbrooke Sherbrooke Quebec Canada
2. Faculté de médecine et des sciences de la santé Université de Sherbrooke Sherbrooke Quebec Canada
3. Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), Centre intégré universitaire de santé et de services sociaux du Saguenay‐Lac‐St‐Jean Saguenay Quebec Canada
4. Centre de recherche du Centre intégré universitaire du Saguenay–Lac‐St‐Jean, Clinique des maladies neuromusculaires Saguenay Quebec Canada
5. Department of Neurology McGill University, Montreal Neurological Institute Montreal Quebec Canada
Abstract
AbstractIntroduction/AimsMuscle weakness, and its association with mobility limitations, has received little study in oculopharyngeal muscular dystrophy (OPMD) using quantitative and standardized assessments. The objectives of this study were to (1) document upper and lower limb muscle strength, upper limb functions, fatigue, and mobility capacities; (2) compare them with reference values and across participant age groups; and (3) explore associations between muscle strength, fatigue, and mobility capacities among adults with OPMD.MethodsThirty‐four participants were included in this cross‐sectional study. The following variables were assessed: quantitative maximal isometric muscle strength, grip and pinch strength, fatigue, walking speed, walking endurance, sit‐to‐stand, and stair ascent and descent capacities.ResultsMuscle strength was lower for older than younger participants for five muscle groups (P < .05). Walking endurance, sit‐to‐stand, stairs (ascent and descent), and strength of hip flexion, grip, and pinch were below 80% of reference values in participants ≥56 y old (55.3%–78.2%). Moderate to strong correlations were found between muscle strength and mobility capacities (ρ = 0.42–0.80, P < .05), and between fatigue and either muscle strength or mobility capacities (ρ = 0.42–0.75, P < .05).DiscussionThis study highlights the impact of OPMD on strength, endurance, and functional capacity, among others, with patients being well below reference values even before the age of 65 y. In addition to helping health professionals to offer better clinical guidance, these results will improve clinical trial readiness. The next steps will be to assess the metrological properties of outcome measures and continue to document the disease progression rate.
Funder
Fonds de Recherche du Québec - Santé
Subject
Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献